Three-Year Outcomes of a Phase II Study of Perioperative Capecitabine Plus Oxaliplatin Therapy for Clinical SS/SE N1-3 M0 Gastric Cancer (OGSG 1601)

by Akamaru, Y., Endo, S., Fujita, S., Fujitani, K., Goto, M., Imano, M., Kato, T., Kawabata, R., Kawakami, H., Kurokawa, Y., Lee, S.-W, Matsuyama, J., Sakai, D., Satoh, T., Shimokawa, T., Taniguchi, H., Tatsumi, M., Terazawa, T.
Published 2022